10.13.26 -- Why CMC Tech Transfer Should Begin With The End In Mind

Small changes in mobile phase, temperature, and column chemistry can affect the detection of GLP-1 peptide impurities. Learn which conditions improve resolution for challenging peptide analyses.

3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.

Platform biotech companies face critical choices on partnering, licensing, or selling technology—decisions that shape focus, valuation, and long‑term success beyond scientific innovation alone.

Nearly 90% of marketed drugs have poor water solubility. See how self-emulsifying drug delivery systems (SEDDS) resolve oral bioavailability failures across BCS Class II and IV compounds.

Explore the ways to design and de-risk molecules, streamlining the path to GMP manufacturing and clinical trials, and case studies that provide insight into key activities.

Integrating process flows, HVAC controls, and cleanability during initial cleanroom planning ensures cGMP compliance and mitigates long-term contamination risks.

Clear connections among QTPP requirements, CQAs, and CPPs help teams preserve process knowledge. Examine how a structured mapping approach supports stronger risk assessments.

Aligning powder rheology, delivery devices, and fill technology early accelerates dry powder inhaler development and secures robust commercial drug production.

Continuous flow manufacturing improves API synthesis through precise mixing and thermal control. Small-volume reactions enhance safety, reduce waste, and ensure consistent product quality.

An accelerated technology transfer reduced time to PPQ by over 25%, overcoming novel raw materials, unique IP constraints, and late‑stage process optimization to meet urgent commercial demand.

Safeguard living medicines with a tailored facility design strategy. Evaluate workflows with this six-dimensional model against your CCS for a holistic look to inform your decisions.

Gain insight into how leveraging a customs warehouse can streamline your supply chain, reduce VAT costs, and enhance global compliance and efficiency.

Patient-derived organoids are revolutionizing drug discovery. Discover a scalable bioprocess that enhances reproducibility and cost-effectiveness to pave the way for broader adoption.

At roughly 600,000 samples per year, manual EM documentation creates real compliance and operational risk. Take a look at how a fully integrated digital sampling system addresses both.

Proactive compliance depends on automation. When asset data drives investigations, enforces change control, and reveals hidden failure patterns, compliance becomes an outcome of strong operations.